FlowAid Medical Tech

FlowAid Medical Technologies Corp. FA100 Sequential Compression Device for #diabetes #circulatory #bloodflow #ulcers #neuropathy #wound #lymphedema

[FlowAid Medical Tech @flowaid]

The FA100 SCCD treats the core issue. Others just treat the symptoms.

[FlowAid Medical Tech @flowaid]

"@chrissyfarr: Like @EricTopol points out [below], there’s no way to stop people from looking up their symptoms online. And while some get the wrong info, I’ve also heard stories of patients *correctly* assessing the problem.." https://t.co/eDKLG3JI0X interesting threads ↑ ↓

[Eric Topol @EricTopol]

While we must denounce the "merchants of medical misinformation,"
I disagree w/ the paternalistic point to "discourage their patients from turning to the internet for answers." There's plenty of useful info, too.
op-ed by @haiderwarraich @nytopinion "https://t.co/hGjQ4JH63p

[FlowAid Medical Tech @flowaid]

[Germany] Impact of diabetes type on treatment and outcome of patients with peripheral artery disease https://t.co/GYkRfVIyO1 fulltext "Our data source consisted of anonymized patient’s data from the largest health insurance in Germany..[of] Patients hospitalized betw 2009 & 2011

[FlowAid Medical Tech @flowaid]

Grandpa, why didn't you start using @flowaid when you stopped getting enough blood circulation in your leg?

[BBC Health News @bbchealth]

Type 2 diabetes affects 7,000 under-25s in England and Wales https://t.co/h7iMfzQ0oT

[Diabetologia @DiabetologiaJnl]

Global trends in diabetes complications: a review of current evidence @CDCgov #diabetescomplications https://t.co/t65I7grEzI #toptweet

[FlowAid Medical Tech @flowaid]

[Brazil] Self-monitoring blood glucose improves glycemic control [in the short-term up to one year] in type 2 diabetes without intensive [insulin] treatment: A systematic review and meta-analysis https://t.co/OPUr8O3yfM abstract

[FlowAid Medical Tech @flowaid]

[US] ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison https://t.co/ywUmdid2yI abstract central illustration https://t.co/ZtUm4EW5vj of similarities and differences

[ᗰIGᑌEᒪ ᗰOᑎTEᖇO-ᗷᗩKEᖇ @monteromiguel]

PAD guidelines: Consensus needed between U.S. and Europe https://t.co/CapvCvSIGr

[FlowAid Medical Tech @flowaid]

[US] Position Statement: DYSGLYCEMIA-BASED CHRONIC DISEASE:
AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT https://t.co/R4BPhqxigR "in the Diabetes Prevention Program..up to 10% of patients [with prediabetes] developed background retinopathy or neuropathy

[Miriam Berchuk MD @MiriamBerchuk]

“Currently, treatment of DBCD often begins at the time of a type 2 diabetes diagnosis,” says statement primary author Jeffrey I. Mechanick. “The clinical implications strongly suggest that initiation of therapy only at Stage 3 or Stage 4 is not an optimal care approach.”

[FlowAid Medical Tech @flowaid]

@asindiadega @lewest between obesity and type 2 diabetes and coronary artery disease - of possible interest - https://t.co/RElJy5zbZa

[Haitham Ahmed, MD, MPH @haithamahmedmd]

Our study in @JAMANetworkOpen of nearly 1 million patients showing #obesity is causal of #heartdisease & #diabetes. Read here: https://t.co/mBVuK7zqIB

Much work to do in fight against rising obesity rates! @JAMA_current @JAMACardio @WorldObesity @American_Heart @AmDiabetesAssn

[FlowAid Medical Tech @flowaid]

"until 2002, type 2 diabetes was not considered a paediatric condition; today, there are an est 3600 children & young adults diagnosed w the condition each year in the USA. In the UK, nearly 7000 cases were reported in 2018.. Disturbingly, this trend is reflected internationally"

[kent buse @kentbuse]

‘Surely children & adolescents can not be held responsible for living in obesogenic environments’ - time to shift focus https://t.co/REX2pVQwRX @WorldObesity @johanna_ralston @MartenRobert @SimonCapewell99 @Unni_Gopinathan @SharonFrielOz @ncdalliance @NCDFREE @PhilBakerNZ

[FlowAid Medical Tech @flowaid]

[Australia] People with diabetes foot complications do not recall their foot education: a cohort study https://t.co/UtmdNxwzeI fulltext “Thinking about your consultation & your foot health, what did the podiatrist tell you about diabetes and problems wi blood flow?” phone survey

[Wounds Canada @WoundsCanada]

People with diabetes foot complications do not recall their foot education: a cohort study https://t.co/LXyTAODz78 #jfar

[FlowAid Medical Tech @flowaid]

ref26 [Netherlands] Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Predicts 5-Year Amputation in Patients With Peripheral Artery Disease https://t.co/udzCzi6spr "in patients at lower Fontaine stage..SAF is the only marker that predicts amputation

[Diabetologia @DiabetologiaJnl]

Non-invasive measurement of skin autofluorescence with an AGE reader can be used in the general population to estimate the risk of #T2D, #cardiovascular disease and #mortality: study in the Lifelines cohort. @umcg @bhrw @researchumcg 🔓 https://t.co/4T0bQ2sH9y

[FlowAid Medical Tech @flowaid]

@karinabronska @Monash_MIHCE Thanks. Re: the stats, we are informed by @djarmstrong: [worldwide] every 20 seconds someone [with diabetes] is amputated [2013] https://t.co/wfsSWZ35AI @IntDiabetesFed | 1 amputation every 20 minutes in South Pacific [updated @WHO Aug 2018] https://t.co/QBRS3QieBc #10000Toes

[FlowAid Medical Tech @flowaid]

[Ghana] @patamot urges people who constantly experience numbness, chronic shooting or burning pains, and needle pain sensations to visit the hospital for proper diagnosis and avoid self-medication. Dr. Amoateng is Senior lecturer at the School of Pharmacy, @UnivofGhana

[Health & Safety TV @hstvgh]

“If we are looking at the scale of all the things that cause neuropathy, we will put diabetes on top” he said. https://t.co/waxi6omyW5

[FlowAid Medical Tech @flowaid]

[US] Resurgence of Diabetes-Related Nontraumatic Lower Extremity Amputation in the Young and Middle-Aged Adult U.S. Population [link below] abstract > two-decade decline in lower extremity amputations, the U.S. may now be experiencing a reversal..partic in young and middle-aged

[Robert Lustig MD @RobertLustigMD]

During the Iraq & Afghanistan wars, 1,500 US soldiers lost a limb in combat. In that same period, over 730,000 US residents lost limbs to amputations resulting from T2D. Sadly, this report shows a resurgence of Diabetes-Related Amputation. https://t.co/EIRfomxryO

[FlowAid Medical Tech @flowaid]

potentially important thread https://t.co/NF1XQSCjnv re "observational..data from the US in @AnnalsofIM [Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort Study https://t.co/oMvYm7c9uE] comparing outcomes

[Abd Tahrani @AbdTahrani]

Interesting observational (not randomised) data from the US in @AnnalsofIM comparing some diabetes outcomes between primary care physicians, nurse specialist and physician assistant. No difference in HbA1c, BP and LDL reductions between groups #diabetes
https://t.co/V9V9fbEAQJ

[FlowAid Medical Tech @flowaid]

important thread re efficacy of medications for type 2 diabetes, questioning real world difference between adherence and non-adherence

[Zaher Toumi MD @ZaherToumi]

@dr_kevinlee @ConscienHealth @thegastricguru @NeilFlochMD @CarlosCgalvani @PaulDavidsonPhD @Mpmok @IfsoSecretariat @Jacquelin_Joyce @IFSOMENAC If people took the medications, would that meet the conditions you have for effective treatment? #obsmuk #Type2diabetes #obesity

[FlowAid Medical Tech @flowaid]

another potentially important thread re efficacy of medication for type 2 diabetes claiming best time for treatment is before t2d onset at prediabetes stage using metformin, pioglitazone, GLP-1 receptor agonist & lifestyle therapy https://t.co/BynTIoE6y6

[Eric Topol @EricTopol]

Of the 84 million Americans at-risk for #diabetes #T2D, 40% will progress over ~5 yrs. Results of this retrospective study supported triple drug for prevention w/ efficacy well beyond lifestyle. Very expensive & provocative.
https://t.co/j55BnQPqfK @TheLancetEndo

[FlowAid Medical Tech @flowaid]

[UK] Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study https://t.co/t6hw39DnWO fulltext

[FlowAid Medical Tech @flowaid]

interesting slide, including this bullet:
* Prevention of a first ulcer remains a neglected area of study

[FlowAid Medical Tech @flowaid]

Grandpa, why didn't you start using @flowaid when you stopped getting enough blood circulation in your leg?

[FlowAid Medical Tech @flowaid]

@BariatricTimes